These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2522597)

  • 1. The dopamine autoreceptor agonist, (+/-)-trans-1,3,4,4a5,10b-hexahydro-4-propyl-2H [1]benzopyrano [3,4-b] pyridin-9-ol hydrochloride (CGS 15855A), modulates striatal dopamine metabolism and prolactin release.
    Iyengar S; Hausler A; Kim HS; Marien M; Altar CA; Wood PL
    Neuropharmacology; 1989 Jan; 28(1):27-31. PubMed ID: 2522597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
    Altar CA; Berner B; Beall P; Carlsen SF; Boyar WC
    Mol Pharmacol; 1988 Jun; 33(6):690-5. PubMed ID: 3380082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain.
    Altar CA; Boyar WC; Wood PL
    Eur J Pharmacol; 1987 Feb; 134(3):303-11. PubMed ID: 3569417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of the dopamine D2 agonist quinelorane on tuberoinfundibular dopaminergic neuronal activity in male and female rats.
    Eaton MJ; Gopalan C; Kim E; Lookingland KJ; Moore KE
    Brain Res; 1993 Nov; 629(1):53-8. PubMed ID: 7904532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
    Gobert A; Rivet JM; Audinot V; Newman-Tancredi A; Cistarelli L; Millan MJ
    Neuroscience; 1998 May; 84(2):413-29. PubMed ID: 9539213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices.
    Altar CA; Boyar WC; Oei E; Wood PL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):115-20. PubMed ID: 3612520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers.
    DeWald HA; Heffner TG; Jaen JC; Lustgarten DM; McPhail AT; Meltzer LT; Pugsley TA; Wise LD
    J Med Chem; 1990 Jan; 33(1):445-50. PubMed ID: 1967318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization.
    Liebman JM; Gerber R; Hall NR; Altar CA
    Psychopharmacology (Berl); 1988; 96(4):477-83. PubMed ID: 3149769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels.
    Cebeira M; Hernandez ML; Rodriguez de Fonseca F; de Miguel R; Fernandez-Ruiz JJ; Ramos JA
    Life Sci; 1991; 48(6):531-41. PubMed ID: 1671524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol.
    Lévesque D; Di Paolo T
    Neurosci Lett; 1988 May; 88(1):113-8. PubMed ID: 2969467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.
    Kelly E; Willcocks AL; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):618-23. PubMed ID: 2819742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral sensitization following subchronic apomorphine treatment--possible neurochemical basis.
    Vaughn DM; Severson JA; Woodward JJ; Randall PK; Riffee WH; Leslie SW; Wilcox RE
    Brain Res; 1990 Aug; 526(1):37-44. PubMed ID: 2150341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.